Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Prosthetic Heart Valve Market size was valued at US$ 6,815.2 million in 2023 and is poised to grow at a significant CAGR of 11.9% from 2024 - 2030. The four chambers of the human heart each have a valve to guarantee that blood only flows in one direction. The blood flows back into the atria or ventricles if any of the heart valves are leaking, constricted, swollen, or ruptured, placing extreme strain on the entire heart. The worst-case scenario here could result in arrhythmia or possibly heart failure. Prosthetic heart valves can be installed to fix the issue, depending on the defect's severity. Due to the aging population, lack of physical activity, and bad diet, demand for this sort of surgery is predicted to increase dramatically over the next few decades in many regions worldwide. In 2050, around 850,000 people will need mechanical heart valves.
Furthermore, according to the World Health Organization, about 2% of patients with cardiovascular diseases (CVDs) have rheumatic heart disorders. Therefore, the market is projected to benefit in the years to come from the rise of rheumatic heart disorders. Additionally, the hunt for an alternative to the replacement heart valves already in use began in 2019 by researchers at ETH Zurich and the South African business SAT. And with some success: they designed a silicone prosthetic heart valve that is produced using 3D printers in several processes.
Study Period
2024-2030Base Year
2023CAGR
11.9%Largest Market
Asia PacificFastest Growing Market
North America
Several healthcare facilities are using new and enhanced technology to give patients better therapies, drugs, and treatments since the healthcare system is rapidly evolving. Numerous government initiatives strongly support these advancements. The Prosthetic heart valve market is expanding, and this trend is projected to continue due to various payment methods and flexible insurance claims.
Furthermore, data is crucial for properly developing and designing heart valves. Players in the market create the highest caliber valves with vital hospital data. Manufacturers are creating smart and intelligent heart valves using data-driven technologies like the Internet of Things and Prosthetic intelligence. In the upcoming years, market growth is anticipated to be driven by the swift adoption of data-driven technologies. However, the Prosthetic valve's high price and risk associated with replacement may constrain the market.
North America is likely to hold a significant revenue share in 2021, and in the following years, it is predicted to increase rapidly. This is due to prominent players operating in these nations, a well-developed healthcare infrastructure, attractive reimbursement regulations, and other factors. Additionally, it is anticipated that rising expansion activities through strategic mergers and acquisitions for customer base expansion and technical developments would further boost the growth of the target market in this area.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 6,815.2 million |
|
Market CAGR |
11.9% |
|
By Product Type |
|
|
By Region |
|
Download Free Sample Report
The global prosthetic heart valve market size was valued at US$ 6,815.2 million in 2023 and is projected to grow at a CAGR of 11.9% from 2024 to 2030.
Edwards Lifesciences, Medtronic, Abbott, Boston Scientific Corporation, LivaNova, Symetis, Jenavalve Technology
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Prosthetic Heart Valve Market Introduction |
| 2.1.Global Prosthetic Heart Valve Market - Taxonomy |
| 2.2.Global Prosthetic Heart Valve Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Geography |
| 2.2.3.Region |
| 3. Global Prosthetic Heart Valve Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Prosthetic Heart Valve Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Prosthetic Heart Valve Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Biological heart valves |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Mechanical heart valves |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Transcatheter heart valves |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Prosthetic Heart Valve Market By Geography, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. North America |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Europe |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. The Asia Pacific |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Latin America |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. MEA |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Prosthetic Heart Valve Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Prosthetic Heart Valve Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Biological heart valves |
| 8.1.2.Mechanical heart valves |
| 8.1.3.Transcatheter heart valves |
| 8.2. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.North America |
| 8.2.2.Europe |
| 8.2.3.The Asia Pacific |
| 8.2.4.Latin America |
| 8.2.5.MEA |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Prosthetic Heart Valve Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Biological heart valves |
| 9.1.2.Mechanical heart valves |
| 9.1.3.Transcatheter heart valves |
| 9.2. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.North America |
| 9.2.2.Europe |
| 9.2.3.The Asia Pacific |
| 9.2.4.Latin America |
| 9.2.5.MEA |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 9.3.7. |
| 10. Asia Pacific (APAC) Prosthetic Heart Valve Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Biological heart valves |
| 10.1.2.Mechanical heart valves |
| 10.1.3.Transcatheter heart valves |
| 10.2. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.North America |
| 10.2.2.Europe |
| 10.2.3.The Asia Pacific |
| 10.2.4.Latin America |
| 10.2.5.MEA |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Prosthetic Heart Valve Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Biological heart valves |
| 11.1.2.Mechanical heart valves |
| 11.1.3.Transcatheter heart valves |
| 11.2. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.North America |
| 11.2.2.Europe |
| 11.2.3.The Asia Pacific |
| 11.2.4.Latin America |
| 11.2.5.MEA |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Prosthetic Heart Valve Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Biological heart valves |
| 12.1.2.Mechanical heart valves |
| 12.1.3.Transcatheter heart valves |
| 12.2. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.North America |
| 12.2.2.Europe |
| 12.2.3.The Asia Pacific |
| 12.2.4.Latin America |
| 12.2.5.MEA |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Edwards Lifesciences |
| 13.2.2.Medtronic |
| 13.2.3.Abbott |
| 13.2.4.Boston Scientific Corporation |
| 13.2.5.LivaNova |
| 13.2.6.Symetis |
| 13.2.7.Jenavalve Technology |
| 13.2.8.Cryolife |
| 13.2.9.TTK Healthcare Limited |
| 13.2.10.Colibri Heart Valve |
| 13.2.11.Lepu Medical Technology |
| 13.2.12.Braile Biom dica |
| 13.2.13.Micro Interventional |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.